MapReviseSelf-testMaterialsDiscussion
Pharmacology & Prescribing
Makerere University · Years 2–4
Structured clerkship notes, clinical cases, textbook page guides, and exam revision tailored for your rotation.
Medicines, dosage forms and administration routes
35 activitiesA structured pharmacology and prescribing companion for medical students in Uganda, bridging pre-clinical mechanisms and clinical prescribing.
Forty-four modules run from foundations and prescribing craft — medicines and routes, pharmacokinetics, pharmacodynamics, rational selection, prescription writing and dispensing — through autonomic, CNS, cardiovascular and blood pharmacology; antimicrobials and stewardship; endocrine, respiratory, gastrointestinal, analgesic and anticancer drug families; adverse reactions, interactions, medication errors and pharmacovigilance; pregnancy, paediatric, geriatric and organ-impairment prescribing; and the Uganda medicines system. Anchored in Lippincott Illustrated Reviews: Pharmacology, the Uganda Clinical Guidelines 2023, the National Medicines Policy and Ugandan dispensing and pharmacovigilance guidance.
Self-paced modules. Each module opens with why it matters and its objectives, then moves through learn (teaching notes), recall (flashcards and mnemonics), apply (clinical checklists, short-answer and discussion prompts) and check (single-best-answer MCQs with explanations).
Students must identify what is being administered before reasoning about action or dose.
Pharmacokinetics I: absorption and distribution
31 activitiesPrescribing begins with predicting whether and how much drug reaches its target.
Pharmacokinetics II: metabolism, elimination and regimen design
41 activitiesStudents must translate drug clearance into safe timing, maintenance dosing and monitoring.
Pharmacodynamics, receptors and dose–response
39 activitiesMechanism-to-effect reasoning prevents a pharmacology course from becoming name memorisation.
Variability in drug response and evidence evaluation
36 activitiesThe same drug and nominal dose may behave differently between patients and across evidence sources.
Rational medicine selection and therapeutic decision-making
39 activitiesDrug knowledge is clinically useful only when students can choose and justify a medicine responsibly.
Prescription writing, medication orders and dose calculations
43 activitiesA complete, legible and executable prescription is the course’s core practical output.
Dispensing interface, counselling and adherence
38 activitiesPrescription success depends on what patients receive, understand and actually take.
Cholinergic pharmacology
37 activitiesThe parasympathetic system gives students their first full mechanism-to-effect drug family.
Adrenergic pharmacology
38 activitiesAdrenergic receptor reasoning underpins critical medicines used across many clinical rotations.
Neuromuscular drugs and anaesthetic pharmacology
35 activitiesThese drug classes have large safety consequences despite being chiefly administered by trained teams.
Sedatives, hypnotics and anxiolytics
42 activitiesSedatives are common yet can produce serious dose-dependent harm.
Antidepressants, antipsychotics and mood-stabilising agents
36 activitiesPsychotropic prescribing relies on comparing mechanisms with delayed benefits and consequential adverse effects.
Antiseizure, neurodegenerative and CNS-stimulant drugs
38 activitiesThese related neuropharmacology families require mechanistic recognition and attention to therapeutic windows.
Antihypertensive and anti-ischaemic pharmacology
38 activitiesUnderstanding haemodynamic drug action is a transferable skill across medicine, maternity and emergency care.
Diuretics and heart-failure pharmacology
38 activitiesFluid and electrolyte consequences must be anticipated whenever medicines modify renal handling or cardiac function.
Antiarrhythmic drugs
34 activitiesElectrical effects and proarrhythmia make this a high-risk, mechanism-dependent area.
Anticoagulants, antiplatelets and haemostatic agents
39 activitiesPrescribers must understand the trade-off between thrombosis prevention and bleeding.
Haematinics and agents affecting blood formation
34 activitiesAnaemia medicines require understanding of substrate deficiency, erythropoiesis and drug toxicity.
Antimicrobial pharmacology: principles and resistance
44 activitiesAntimicrobial drug selection is unintelligible without spectrum, killing mechanisms and resistance.
Antibacterial drugs I: cell-wall and membrane targets
38 activitiesCell-wall drugs are central and numerous enough to merit focused comparative study.
Antibacterial drugs II: protein, folate and nucleic-acid targets
38 activitiesThis complementary antibacterial module enables mechanism-based comparisons across non-beta-lactam classes.
Antimycobacterial drugs
38 activitiesTuberculosis pharmacology is important in Uganda and has distinctive resistance and adherence challenges.
Antiretrovirals and other antiviral drugs
38 activitiesHIV pharmacology is a core Ugandan prescribing challenge and a major source of interactions.
Antifungal drugs
40 activitiesAntifungal pharmacology requires distinctions between fungal targets, toxicities and treatment feasibility.
Antimalarial, antiprotozoal and anthelmintic drugs
34 activitiesParasite pharmacology is essential for Uganda while remaining conceptually distinct from antibacterial treatment.
Antimicrobial stewardship and antibiotic prescribing review
39 activitiesCorrect drug knowledge is insufficient if every infection receives an unnecessarily broad or prolonged antibiotic.
Antidiabetic drugs
39 activitiesThese agents illustrate the interaction of endocrine physiology, dosage forms, hypoglycaemia and comorbidity.
Thyroid, pituitary and adrenal pharmacology
39 activitiesEndocrine pharmacology rewards understanding of hormone replacement, feedback and suppression.
Sex hormones, reproductive drugs and medicines affecting bone
35 activitiesThese drugs connect receptor pharmacology with fertility, contraception and musculoskeletal health.
Respiratory and allergy pharmacology
37 activitiesRespiratory and histamine drugs show how receptor selectivity affects efficacy and systemic harm.
Gastrointestinal drugs and antiemetics
34 activitiesCommon symptom-control drugs have distinctive targets, interaction burdens and long-term harms.
Selected urological and dermatological pharmacology
34 activitiesSome smaller but useful drug families have no coherent home in major mechanism modules.
Autacoids, NSAIDs and non-opioid analgesics
39 activitiesPain and inflammatory medicines are extremely common and frequently harm the kidney or gastrointestinal tract.
Opioid pharmacology and analgesic safety
30 activitiesOpioids require dedicated consideration of receptors, respiratory toxicity and controlled prescribing.
Anticancer and immunosuppressive pharmacology
36 activitiesStudents need a class-level understanding of cytotoxicity and immune modulation without being taught to prescribe specialist protocols.
Adverse drug reactions and clinical toxicology
36 activitiesRecognising a medicine as the cause of illness is a fundamental clinical skill.
Drug interactions and polypharmacy
36 activitiesMultiple medicines alter exposure and effect in ways learners should anticipate systematically.
Medication errors, safe systems and pharmacovigilance
33 activitiesPrescribing safety depends on recognising near misses, checking systems and reporting harm.
Prescribing in pregnancy and lactation
37 activitiesPregnancy changes drug handling and adds fetal or infant safety considerations.
Paediatric prescribing and dose safety
37 activitiesChild-specific physiology and arithmetic errors can make normal adult prescribing unsafe.
Geriatric prescribing and frailty-related risk
43 activitiesOlder adults often experience adverse effects from multiple interacting medicines and reduced physiological reserve.
Prescribing in renal and hepatic impairment
38 activitiesOrgan dysfunction can turn a normally safe dose into a harmful regimen.
Uganda medicines system, essential medicines and pharmacoeconomics
39 activitiesPrescribing must work within the health system and the patient's financial reality.